Among these analyses, those related to the BRCA1 and BRCA2 genes emerge as extremely important since their mutations are responsible for approximately 5 to 10% of breast and 15% of ovarian cancers (Melchor and Benítez 2013). The gene discussed is BRCA1; the disease is ovarian cancer.